✦ LIBER ✦

703 POSTER A phase I and pharmacokinetic (PK) study of BIBW 2992, an oral irreversible dual EGFR/HER2 inhibitor

✍ Scribed by R. Plummer; L. Vidal; R. Perrett; J. Spicer; P. Stopfer; M. Shahidi; G. Temple; A. Futreal; H. Calvert; J. de Bono

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

573 POSTER Phase I study of BIBW2992, an

✍ R. Plummer; L. Vidal; L. Li; H. Shaw; R. Perrett; M. Shahidi; A. Amelsberg; G. T 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 67 KB

567 POSTER Efficacy of BIBW 2992, an irr

✍ F. Solca; A. Baum; F. Himmelsbach; A. Amelsberg; G. Adolf 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A phase I dose escalation study of BIBW

✍ Eskens, F A L M; Mom, C H; Planting, A S T; Gietema, J A; Amelsberg, A; Huisman, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 173 KB

Phase I pharmacokinetic studies evaluati

✍ Aimee K. Bence; Eric B. Anderson; Maqbool A. Halepota; Michael A. Doukas; Philli 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 170 KB

6560 POSTER A Phase I Safety and Pharmac

✍ Peveling-Oberhag, J.; Zeuzem, S.; Yong, W.R.; Kunz, T.; Paquet, T.; Bouillaud, E 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

386 POSTER Pharmacokinetic (PK) and phar

✍ T.A. Yap; J. Barriuso; S. Frentzas; R. Riisnaes; J. Clark; J. Dukes; A. Futreal; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB